BioCentury
ARTICLE | Company News

Matrix NDA accepted for filing

March 7, 2001 8:00 AM UTC

The FDA accepted for filing MATX's NDA for its IntraDose cisplatin/epinephrine injectable gel to treat refractory or recurrent head and neck cancer. ...